BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 25966104)

  • 1. IGFBP-3 A-202C and C2133G polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
    Xu J; Xu L; Li LT; You Q; Cha LS
    Genet Mol Res; 2015 Apr; 14(2):3370-86. PubMed ID: 25966104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in the IGF-IGFR-IGFBP axis confer susceptibility to lung and esophageal cancer.
    Huang XP; Zhou WH; Zhang YF
    Genet Mol Res; 2014 Jan; 13(1):2107-19. PubMed ID: 24615087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of IGFBP-3 gene polymorphisms with colorectal cancer: evidence from 17,380 subjects.
    Ge W; Li Y; Xiang H; Li H
    Mol Biol Rep; 2014; 41(4):2609-15. PubMed ID: 24464126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the association between insulin-like growth factor binding protein 3 genetic polymorphisms and colorectal cancer susceptibility.
    Xiang H; Wang Y; Nie S
    PLoS One; 2013; 8(3):e59665. PubMed ID: 23527244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of an exon 1 polymorphism in the IGFBP3 gene with circulating IGFBP-3 levels and colorectal cancer risk: the multiethnic cohort study.
    Le Marchand L; Kolonel LN; Henderson BE; Wilkens LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1319-21. PubMed ID: 15894694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
    Li YL; Tian Z; Zhao L; Zhang CL
    Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
    Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
    Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common polymorphisms in the HIF-1α gene confer susceptibility to digestive cancer: a meta-analysis.
    Xu JJ; Zou LY; Yang L; He XL; Sun M
    Genet Mol Res; 2014 Aug; 13(3):6228-38. PubMed ID: 25158249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
    Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
    J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated meta-analysis on the association of TGF-β1 gene promoter -509C/T polymorphism with colorectal cancer risk.
    Wang Y; Yang H; Li L; Xia X
    Cytokine; 2013 Jan; 61(1):181-7. PubMed ID: 23084539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer.
    Ma X; Kang H; Dai Z; Ma L; Jin Y; Wang X
    Biomed Pharmacother; 2015 Apr; 71():108-11. PubMed ID: 25960224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB1 C3435T polymorphism and the risk of coronary heart disease: a meta-analysis.
    Jin Y; Wang Q; Wang G; Zhang X; Yan B; Hu W
    Genet Test Mol Biomarkers; 2014 Mar; 18(3):164-73. PubMed ID: 24328528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclooxygenase-2 -765G>C polymorphism and susceptibility to colorectal cancer: a meta-analysis].
    Chen X; Dong W; Wang J; Lyu X; Lei H; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Jan; 48(1):62-6. PubMed ID: 24713293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
    Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF1(CA)19 and IGFBP-3-202A/C gene polymorphism and cancer risk: a meta-analysis.
    Quan H; Tang H; Fang L; Bi J; Liu Y; Li H
    Cell Biochem Biophys; 2014 May; 69(1):169-78. PubMed ID: 24310658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase genetic polymorphisms and colorectal cancer risk: a meta-analysis.
    Wang J; Shi D; Guo X; Zhang J; Yu S; Song J; Cao Z; Wang J; Ji M; Dong W
    Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):481-90. PubMed ID: 24685603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the association of IGFBP3 and IGF1 polymorphisms with susceptibility to colorectal cancer.
    Wang W; Wu BQ; Chen GB; Zhou Y; Li ZH; Zhang JL; Ding YL; Zhang P; Wang JQ
    Neoplasma; 2018 Nov; 65(6):855-864. PubMed ID: 30334445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.